Literature DB >> 17034701

Hepatic histopathological findings in HIV patients at postmortem in Jos university teaching hospital, Nigeria.

Godwins O Echejoh1, Barnabas M Mandong, Matthew N Tanko, Agabus N Manasseh, Edith N Okeke, Emmanuel I Agaba.   

Abstract

Multi-organ involvement by opportunistic infections and neoplasms is the major cause of morbidity and mortality in people living with HIV/AIDS. We determined the spectrum/frequency of hepatic histopathological lesions in a prospective study of postmortem liver biopsies from 100 patients (50 females and 50 males, age range 18-55 years) who died from HIV/AIDS in Jos university teaching hospital, Nigeria. The majority of the patients, 65 (65%), had clinical tuberculosis. Granulomatous hepatitis, chronic hepatitis, non-specific reactive hepatitis (NSRH) and steatosis were the commonest hepatic histopathologic lesions occurring in 34, 20,15 and 12% of patients, respectively. Seven (7%) had normal histological features. This study shows that the liver is affected in HIV/AIDS as reported elsewhere in the world. Therefore, liver biopsy in HIV patients may be helpful in the management of these patients.

Entities:  

Mesh:

Year:  2006        PMID: 17034701     DOI: 10.1258/004947506778604832

Source DB:  PubMed          Journal:  Trop Doct        ISSN: 0049-4755            Impact factor:   0.731


  2 in total

1.  The prevalence and drug sensitivity of tuberculosis among patients dying in hospital in KwaZulu-Natal, South Africa: a postmortem study.

Authors:  Ted Cohen; Megan Murray; Kristina Wallengren; Gonzalo G Alvarez; Elizabeth Y Samuel; Douglas Wilson
Journal:  PLoS Med       Date:  2010-06-22       Impact factor: 11.069

Review 2.  Clinicopathological correlates in HIV seropositive tuberculosis cases presenting with jaundice after initiating antiretroviral therapy with a structured review of the literature.

Authors:  David A Barr; Pravistadevi K Ramdial
Journal:  BMC Infect Dis       Date:  2012-10-14       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.